#Latest news with #OncoCyteWashington Post12-05-2025BusinessWashington PostOncoCyte: Q1 Earnings SnapshotIRVINE, Calif. — IRVINE, Calif. — OncoCyte Corp. (OCX) on Monday reported a loss of $6.7 million in its first quarter. The Irvine, California-based company said it had a loss of 26 cents per share. The cancer diagnostic test developer posted revenue of $2.1 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on OCX at
Washington Post12-05-2025BusinessWashington PostOncoCyte: Q1 Earnings SnapshotIRVINE, Calif. — IRVINE, Calif. — OncoCyte Corp. (OCX) on Monday reported a loss of $6.7 million in its first quarter. The Irvine, California-based company said it had a loss of 26 cents per share. The cancer diagnostic test developer posted revenue of $2.1 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on OCX at